Search

Your search keyword '"Pasini, Luisa"' showing total 135 results

Search Constraints

Start Over You searched for: Author "Pasini, Luisa" Remove constraint Author: "Pasini, Luisa"
135 results on '"Pasini, Luisa"'

Search Results

1. PD13-12 DIAGNOSTIC PERFORMANCE OF MICROULTRASOUND AT CONFIRMATORY RECLASSIFICATION BIOPSY IN PATIENTS UNDER ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER

2. Prospective Evaluation of 68Ga-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography in Primary Prostate Cancer Diagnosis

4. Imaging predictive biomarkers of response in patients with prostate cancer undergoing high-intensity focused ultrasound (HIFU) focal therapy.

5. 68Ga-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study

8. Diagnostic performance of microUltrasound at MRI‐guided confirmatory biopsy in patients under active surveillance for low‐risk prostate cancer

9. MP73-16 SUV VARIATION ON PSMA PET/CT CORRELATES WITH BIOCHEMICAL RESPONSE IN PATIENTS WITH PROSTATE CANCER UNDERGOING HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) FOCAL THERAPY

10. Active Surveillance for Low Risk Nonmuscle Invasive Bladder Cancer: A Confirmatory and Resource Consumption Study from the BIAS Project

19. Miniperc? No, Thank You!

22. Predictive factors for progression of patients with carcinoma in situ of the bladder at long-term follow-up: pure versus non-pure CIS

23. PD18-05 XPERTBLADDER MONITOR TEST FOR FAILURE DEFINITION OF PATIENTS UNDER ACTIVE SURVEILLANCE FOR RECURRENT LOW-RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) WITH NEGATIVE CITOLOGY

25. Long-term outcomes of high-grade T1 bladder cancer treated with intravesical bacillus Calmette-Guérin: experience of a single center

26. 68 Ga-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study

27. MP64-07 VASCULAR HURST INDEX IN NON-TUMORAL BIOPSY CORES AS POTENTIAL HISTOPATHOLOGICAL PARAMETER TO SELECT PATIENTS WITH HIDDEN PROSTATE CANCER

28. PD06-11 68GA-PSMA PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER IN MEN WITH CONTRAINDICATIONS TO OR NEGATIVE MRI: A PROSPECTIVE OBSERVATIONAL STUDY

29. MP05-18 EARLY VERSUS STANDARD CATHETER REMOVAL AFTER COMPLETE ANATOMICAL RECONSTRUCTION DURING ROBOT-ASSISTED RADICAL PROSTATECTOMY: RESULTS FROM A PROSPECTIVE SINGLE-INSTITUTIONAL RANDOMIZED TRIAL (RIPRECA)

30. MP55-17 NEW CONCEPTION FOR FLEXOR VUE DEFLECTING ENDOSCOPIC SYSTEM USE, IN ORDER TO IMPROVE STONE FREE RATE (SFR) AFTER RIRS: PRELIMINARY RESULTS FROM A SINGLE CENTRE STAGE 2A STUDY

31. MP64-17 EXTRACELLULAR COLLAGENIC TYPE AND STRUCTURAL ORGANIZATION CHANGES IN PROSTATE CANCER AND BENIGN PROSTATIC HYPERPLASIA

32. MP20-14 POSITIVE PROSTATE 68GAPSMA-PET/CT CORRELATES WITH DETECTION OF CD45-/PSMA+ NON-SPERM EPITHELIAL CELLS OBTAINED BY LIQUID BIOPSY OF SEMINAL FLUID IN PATIENTS WITH PROSTATE CANCER (PCA).

33. PD35-12 RETROGRADE INTRARENAL SURGERY - SINGLE HAND (RIRS-SH) BY NEW A SEMI-FLEXIBLE URETEROSCOPY FOR MEDIUM SIZE (1.5 TO 2 CM) RENAL STONE: PRELIMINARY RESULTS FROM A SINGLE CENTRE STAGE 2A STUDY

34. Targeted 11C–choline PET-CT/TRUS software fusion-guided prostate biopsy in men with persistently elevated PSA and negative mpMRI after previous negative biopsy

35. MP28-04 SENSITIVITY OF [-2]PROPSA (P2PSA) MEASUREMENTS FOR PREDICTION OF BIOCHEMICAL RECURRENCE (BCR) IN MEN AFTER RADICAL PROSTATECTOMY: A 3-YEARS PROSPECTIVE COHORT STUDY

36. MP77-03 TARGETED 11C-CHOLINE PET/CT/TRUS SOFTWARE FUSION-GUIDED PROSTATE BIOPSY HAS IN MEN WITH PERSISTENTLY ELEVATED PSA AFTER PREVIOUS NEGATIVE BIOPSY

37. MP03-18 ABSENCE OF LEARNING CURVE IMPACT MAY LET MRI-TRUS FUSION GUIDED BIOPSY UP FOR EARLY DIAGNOSIS OF PROSTATE CANCER

38. PD19-01 ACTIVE SURVEILLANCE FOR NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC): RESULT FROM BLADDER CANCER ITALIAN ACTIVE SURVEILLANCE (BIAS) PROJECT.

39. Impact of a teaching program on outcome quality of white light transurethral resection for bladder tumor: A cohort study

40. Active surveillance for low-risk non-muscle-invasive bladder cancer: mid-term results from the Bladder cancer Italian Active Surveillance (BIAS) project

41. Mid-Term Follow-Up of “En Bloc” Resection of Nonmuscle Invasive Bladder Cancer: Results from a Prospective Single-Center Study

42. MP02-01 CLINICAL UTILITY OF PHI (PROSTATE HEALTH INDEX) IN MEN WITH TPSA > 10 NG/ML. RESULTS FROM A MULTICENTRIC EUROPEAN STUDY

43. MP16-07 SHOULD WE CONTINUE TO BIOPSY MEN WITH PI-RADS III AFTER PREVIOUS NEGATIVE BIOPSY?

44. “En Bloc” Resection of Nonmuscle Invasive Bladder Cancer: A Prospective Single-center Study

45. Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans: an update on the evidence

46. Preoperative prostate health index is an independent predictor of early biochemical recurrence after radical prostatectomy: Results from a prospective single-center study

50. Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans: an update on the evidence.

Catalog

Books, media, physical & digital resources